In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The endometrium, the inner lining of the uterus, is the layer of tissue that thickens every month in ...

Combined GLP 1 receptor agonists and progestin therapy reduces endometrial cancer risk and hysterectomy rates in women with benign uterine conditions.

Patients using GLP-1 agonists had a significantly lower hysterectomy rate over 2-year and 5-year follow-up. Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin ...

Notice your periods getting heavier or lasting longer? While fibroids are common, oncologist Dr Dabas explains when it could ...

I didn't really completely unpack what I was feeling," 'The Nanny' alum said of how she tried to cope with her trauma ...

—A study that explored trends in obesity and endometrial cancer in the U.S concluded that the combination of the 2 conditions hits younger women, and Black and Hispanic women in particular, the ...

Fran Drescher opens up about her uterine cancer battle, reflecting on how unresolved emotional trauma may have contributed to ...

Tiffany White was 27 years old when she was diagnosed with endometrial cancer. White, a Chicago resident who works as a mental health counselor and an accounting director for a national nonprofit ...

Can adding a GLP-1 to standard progestin therapy for nonmalignant uterine conditions lower women’s risk of developing endometrial cancer?